IN BRIEF: Open Orphan non-exec Mo Khan switches to chief executive

Open Orphan PLC - London-based pharmaceutical services - Moves Non-Executive Director Mo Khan to ...

Alliance News 24 February, 2022 | 2:48PM
Email Form Facebook Twitter LinkedIn RSS

Open Orphan PLC - London-based pharmaceutical services - Moves Non-Executive Director Mo Khan to chief executive officer, effective immediately. Khan had joined the Open Orphan board back in October. The company notes he has 25 years of clinical research experience. Cathal Friel remains executive chair, while Open Orphan will aim to find a new independent non-executive director within the next six months.

Current stock price: 13.53 pence, down 9.8% on Thursday

12-month change: down 50%

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Open Orphan PLC 14.76 GBX 9.33 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.